Skip to content

Using Bedside Ultrasound to Understand Fluid Management in Patients With Chronic Liver Disease

POCUS Guided Fluid Resuscitation in Cirrhosis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07810855
Acronym
POCUS-C
Enrollment
100
Registered
2026-09-09
Start date
2026-09-01
Completion date
2027-04-01
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis, Ascites Hepatic, Fluid Balance

Brief summary

The goal of this observational study is to see if repeated bedside ultrasound measurements of the lungs and abdomen as well as a blood vessel in the neck can be done in patients with advanced liver disease and ascites (fluid in the abdomen) on hospital wards and day case units. We will also learn about how patients view this test. The main questions it will answer are: How long does it take to do the measurements? How often are we able to get all the measurements we are trying to do? How do patients feel about having this test done? For patients in the study this will involve: Undergoing ultrasound scans of the neck, chest and abdomen on at least one occasion during hospital admission, and up to a maximum of five times in a day. An extra blood test may be taken at the same time as usual blood tests taken during the hospital stay. A brief questionnaire about their experience of having the test.

Interventions

DIAGNOSTIC_TESTUltrasound measurement

Point-of-care ultrasound measurements of the IJV, IVC, thorax and abdomen performed at least once following recruitments and on up to three separate occasions in total during the first seven days of admission, with up to five measurements in total on each occasion.

A blood sample for research analysis may be taken at the same time as standard of care blood tests during the study.

Sponsors

Royal Free Hospital NHS Foundation Trust
Lead SponsorOTHER
Royal Free Charity
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants must be capable of giving informed consent * Hospitalized patients with liver cirrhosis (of any cause) and clinically significant ascites * \> 18 years of age

Exclusion criteria

* patients receiving end of life care

Design outcomes

Primary

MeasureTime frameDescription
Technical success or failure of POCUS readingsFrom enrollment until the end of the POCUS readings period at 7 daysThe number of POCUS scans attempted that resulted in a recorded measurement
Duration of POCUS readingsFrom enrolment until the end of the POCUS readings period at 7 daysTime taken to perform each episode of POCUS during the study period, defined by the start and end times recorded in the case report form
Patient acceptabilityFrom enrollment until the end of the POCUS readings period at 7 daysStructured feedback from participants on the acceptability of the POCUS readings via a questionnaire

Secondary

MeasureTime frameDescription
Correlation of POCUS readings with clinical assessmentFrom enrolment until end of POCUS readings period (7 days)A descriptive analysis of how frequently baseline clinical assessments agreed with POCUS findings suggestive of hypovolaemia or hypervolaemia
Changes in POCUS measurements in response to fluid management interventionsFrom enrolment until the end of POCUS readings period at 7 daysThe delta of POCUS readings before and after fluid management interventions (intravenous fluid or albumin, diuretics, terlipressin or large volume paracentesis)
Correlation of POCUS readings with clinical outcomesFrom enrolment until 90 daysA descriptive analysis of POCUS parameters and predefined clinical outcomes (emergency readmission to hospital, renal dysfunction, fluid overload/pulmonary oedema, variceal bleeding, hepatic encephalopathy, other organ dysfunction/ACLF grade, ICU admission and death)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026